RxDoctor Payments Data

Jasmaine Theobald, APRN

Family · Calvert City, KYNPI 1346624962

Payments from drug & device makers

$1,058in general payments, 2019–2025

Across 57 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$241
  • Xeris Pharmaceuticals, Inc.$151
  • Novo Nordisk$132
  • Pfizer$100
  • Boehringer Ingelheim$73
  • Novartis$55
  • plus $306 from 11 others

What the payments were for

  • Food & beverage$1,058100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,058 in reported general payments places this provider in the 65th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$3,529
Medicare patients
73
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide20$33,132
OzempicSemaglutide19$29,195
EliquisApixaban16$15,193
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$15,017
FarxigaDapagliflozin Propanediol12$13,518
SymbicortBudesonide/Formoterol Fumarate12$3,168
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,097
Estradiol16$1,915
Albuterol Sulfate HfaAlbuterol Sulfate45$1,287
Desvenlafaxine Succinate ErDesvenlafaxine Succinate13$1,223
Ventolin HfaAlbuterol Sulfate14$1,117
Atorvastatin Calcium90$898
Pantoprazole Sodium76$827
Celecoxib34$739
Duloxetine Hcl23$629

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$46$33,13220 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$32$31,70248 claims
Novo NordiskOzempic$132$29,19519 claims
PfizerEliquis$100$15,19316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,374 family providers in Kentucky.

Other family in Calvert City

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →